Provider QP75-20 Commercial Pharmacy Benefit Exclusion for Aralast®NP, Eylea®, Glassia®, Lucentis®, Prolastin®-C, and UpliznaTM Read More
Provider QP70-20 In-Home Test Kits 2020 Program Details for Medicare Advantage and SecureBlue Members Read More
Provider Reduction Mammoplasty Commercial Pre-Authorization Request Form (Medical Policy IV-32) (PDF) Read More
Provider P28R1-20 Update: Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program Read More
Provider P57-20 Site of Service Program Updates for Selected Specialty Medical Drugs for Commercial Subscribers: Medical Policy XI-06 Read More
Provider P58-20 Hereditary Angioedema (HAE) Drug Prior Authorization Management Changes for generic Icatibant, Firazyr, Haegarda, and Takhzyro — Effective October 5, 2020 Read More
Provider P56-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective October 5, 2020 Read More
